Aurora Cannabis Expects Q3 Cannabis Net Revenue To Be Largely Similar To Fiscal Q2 2024, With The Geographical Mix Slightly Weighted Further Towards The International Medical Segment
Portfolio Pulse from Benzinga Newsdesk
Aurora Cannabis expects its Q3 2024 cannabis net revenue to be similar to that of Q2 2024, with a slight increase in the international medical segment. The company also anticipates seasonally reduced revenues and gross profit for plant propagation in Q3 2024, consistent with Q2 2024 and historical performance.
November 09, 2023 | 9:40 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Aurora Cannabis expects Q3 2024 revenues to be similar to Q2 2024, with a slight increase in the international medical segment. Seasonally reduced revenues are expected for plant propagation.
The news directly pertains to Aurora Cannabis' revenue expectations for Q3 2024. The company expects similar revenues to Q2 2024, indicating stable performance. However, the impact on the stock price is neutral as the news does not suggest significant growth or decline.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100